[1]
Hamanaka, J. et al. 2017. Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma. Turkish Journal of Gastroenterology. 28, 3 (Jan. 2017), 197–201. DOI:https://doi.org/10.5152/tjg.2017.16641.